Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Do Statins Improve Nasopharyngeal Cancer Outcomes?
TOPLINE: Statin use during concurrent chemoradiotherapy (CCRT) for advanced nasopharyngeal cancer (NPC) is associated with a 52% reduction in all-cause mortality. Higher cumulative defined daily doses of statins correlate with improved survival outcomes, particularly with rosuvastatin and atorvastatin. METHODOLOGY: Statins…
English